Long-term vemurafenib treatment drives inhibitor resistance through a spontaneous KRAS G12D mutation in a BRAF V600E papillary thyroid carcinoma model

Por Danysh, Brian P., Rieger, Erin Y., Sinha, Deepankar K., Evers, Caitlin V., Cote, Gilbert J., Cabanillas, Maria E., Hofmann, Marie-Claude
Publicado no Oncotarget (2016)